Skip to main content
Equibles
PLX $2.73 +0.74%
PLX logo
PLX · Protalix BioTherapeutics, Inc.
Track PLX — free

Use PLX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PLX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.73 +0.02 (+0.74%) At close · Oct 6
Russell 2000 member Rebalance outlook locked
Market Cap
$219.15M
Shares
80.57M
Volume · Oct 6 934.74K Avg daily vol (3M) 729.19K
All webcasts

Earnings call · FY2024 Q4

Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call

Concluded Mar 17, 2025
Mar 17, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $18.22M +73.7% YoY
Net income · derived Q4 $6.49M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 17, 2025 10-K report Filed Mar 17, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

PLX transcript alerts

Protalix BioTherapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →